
Nootropic Peptides

For in vitro research only
A synthetic heptapeptide analog of tuftsin supplied as a 10 mg lyophilized vial for research into anxiolytic activity, cognition, and neuroimmune modulation.
Quantity
Promotion
Everything you need to start is included.
New
Technical specification
Key attributes
Each vial is intended for laboratory use only.
Research usage
Selank is a synthetic heptapeptide derived from the endogenous immunomodulatory peptide tuftsin, developed as a research tool for studying anxiolytic and nootropic activity. In preclinical models, it is investigated for its influence on GABAergic and serotonergic signalling, as well as its reported effects on the expression of brain-derived neurotrophic factor (BDNF). Research has explored the peptide as a stable analog that resists rapid enzymatic degradation, positioning it as a subject of interest in neuropharmacology models. It is commonly studied in rodent behavioural paradigms to examine mechanisms related to stress response and cognition. Selank is used strictly as a reference compound in laboratory research settings.
Research in animal models reports that Selank modulates the balance of GABAergic and serotonergic neurotransmission and may influence the expression of BDNF and other markers associated with neural plasticity. Rodent studies have described anxiolytic-like and cognition-related effects without the sedative profile reported for some classical anxiolytics. Additional investigations have reported immunomodulatory and neuroprotective properties consistent with its tuftsin-derived structure. These observations have positioned Selank as a subject of ongoing interest in anxiolytic, nootropic and neuroimmune research models.
The full pharmacological and toxicological profile of Selank has not been completely characterized in research models, and the available data are derived primarily from preclinical and animal studies. It should be handled only by qualified personnel using appropriate laboratory practices and personal protective equipment. As with all research peptides, it should be kept away from unauthorized access and must not be ingested or otherwise introduced into the body. This material is intended solely for controlled in vitro and preclinical investigation.

Nootropic Peptides
Research journal
Selank is a tuftsin-derived synthetic peptide studied in preclinical models for anxiety-related and stress pathways.
Semax is a synthetic peptide from an ACTH fragment, studied in preclinical models for cognition and neuroprotection.